Evidence map›Paper›PMID 40080457›Full record

ArticlePloS one2025

Sine-G family of distributions in Bayesian survival modeling: A baseline hazard approach for proportional hazard regression with application to right-censored oncology datasets using R and STAN.

Abdisalam Hassan Muse, Amani Almohaimeed, Hana N Alqifari, Christophe Chesneau

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abdisalam Hassan MuseResearch and Innovation Centre, Amoud University, Amoud valley, Borama, Somalia.
Amani AlmohaimeedDepartment of Statistics and Operations Research, College of Science, Qassim University, Buraydah, Saudi Arabia.ORCID https://orcid.org/0000-0002-3205-0921
Hana N AlqifariDepartment of Statistics and Operations Research, College of Science, Qassim University, Buraydah, Saudi Arabia.
Christophe ChesneauDepartment of Mathematics, LMNO, CNRS-Université de Caen, Campus II, Caen, France.ORCID https://orcid.org/0000-0002-1522-9292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In medical research and clinical practice, Bayesian survival modeling is a powerful technique for assessing time-to-event data. It allows for the incorporation of prior knowledge about the model's parameters and provides a more comprehensive understanding of the underlying hazard rate function. In this paper, we propose a Bayesian survival modeling strategy for proportional hazards regression models that employs the Sine-G family of distributions as baseline hazards. The Sine-G family contains flexible distributions that can capture a wide range of hazard forms, including increasing, decreasing, and bathtub-shaped hazards. In order to capture the underlying hazard rate function, we examine the flexibility and effectiveness of several distributions within the Sine-G family, such as the Gompertz, Lomax, Weibull, and exponentiated exponential distributions. The proposed approach is implemented using the R programming language and the STAN probabilistic programming framework. To evaluate the proposed approach, we use a right-censored survival dataset of gastric cancer patients, which allows for precise determination of the hazard rate function while accounting for censoring. The Watanabe Akaike information criterion and the leave-one-out information criterion are employed to evaluate the performance of various baseline hazards.

Indexed as

Bayes TheoremNeoplasmsProportional Hazards ModelsHumansSurvival Analysis

Identifiers

PMID40080457
PMCPMC11906061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.